United States Specific Cancer Immunotherapy Drugs Market Report 2017

January 2017 | 101 pages | ID: U4E712AEC01EN
QYResearch

Abstracts

Notes:

Sales, means the sales volume of Specific Cancer Immunotherapy Drugs

Revenue, means the sales value of Specific Cancer Immunotherapy Drugs

This report studies sales (consumption) of Specific Cancer Immunotherapy Drugs in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering

• Amgen
• Roche
• Bristol Myers Squibb
• Dendreon (Valeant)
• Novartis
• Seattle Genetics
• Hangzhou Jinjiang Group

Market Segment by States, covering

• California
• Texas
• New York
• Florida
• Illinois

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into

• Tablet
• Injection

Split by applications, this report focuses on sales, market share and growth rate of Specific Cancer Immunotherapy Drugs in each application, can be divided into

• Leukemia Treatment
• Colorectal Cancer Treatment
• Other Cancer Treatment

Contents

United States Specific Cancer Immunotherapy Drugs Market Report 2017

1 SPECIFIC CANCER IMMUNOTHERAPY DRUGS OVERVIEW

1.1 Product Overview and Scope of Specific Cancer Immunotherapy Drugs
1.2 Classification of Specific Cancer Immunotherapy Drugs
  1.2.1 Tablet
  1.2.2 Injection
1.3 Application of Specific Cancer Immunotherapy Drugs
  1.3.1 Leukemia Treatment
  1.3.2 Colorectal Cancer Treatment
  1.3.3 Other Cancer Treatment
1.4 United States Market Size Sales (Volume) and Revenue (Value) of Specific Cancer Immunotherapy Drugs (2011-2021)
  1.4.1 United States Specific Cancer Immunotherapy Drugs Sales and Growth Rate (2011-2021)
  1.4.2 United States Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2011-2021)

2 UNITED STATES SPECIFIC CANCER IMMUNOTHERAPY DRUGS COMPETITION BY MANUFACTURERS

2.1 United States Specific Cancer Immunotherapy Drugs Sales and Market Share of Key Manufacturers (2015 and 2016)
2.2 United States Specific Cancer Immunotherapy Drugs Revenue and Share by Manufactures (2015 and 2016)
2.3 United States Specific Cancer Immunotherapy Drugs Average Price by Manufactures (2015 and 2016)
2.4 Specific Cancer Immunotherapy Drugs Market Competitive Situation and Trends
  2.4.1 Specific Cancer Immunotherapy Drugs Market Concentration Rate
  2.4.2 Specific Cancer Immunotherapy Drugs Market Share of Top 3 and Top 5 Manufacturers
  2.4.3 Mergers & Acquisitions, Expansion

3 UNITED STATES SPECIFIC CANCER IMMUNOTHERAPY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY STATES (2011-2016)

3.1 United States Specific Cancer Immunotherapy Drugs Sales and Market Share by States (2011-2016)
3.2 United States Specific Cancer Immunotherapy Drugs Revenue and Market Share by States (2011-2016)
3.3 United States Specific Cancer Immunotherapy Drugs Price by States (2011-2016)

4 UNITED STATES SPECIFIC CANCER IMMUNOTHERAPY DRUGS SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (2011-2016)

4.1 United States Specific Cancer Immunotherapy Drugs Sales and Market Share by Type (2011-2016)
4.2 United States Specific Cancer Immunotherapy Drugs Revenue and Market Share by Type (2011-2016)
4.3 United States Specific Cancer Immunotherapy Drugs Price by Type (2011-2016)
4.4 United States Specific Cancer Immunotherapy Drugs Sales Growth Rate by Type (2011-2016)

5 UNITED STATES SPECIFIC CANCER IMMUNOTHERAPY DRUGS SALES (VOLUME) BY APPLICATION (2011-2016)

5.1 United States Specific Cancer Immunotherapy Drugs Sales and Market Share by Application (2011-2016)
5.2 United States Specific Cancer Immunotherapy Drugs Sales Growth Rate by Application (2011-2016)
5.3 Market Drivers and Opportunities

6 UNITED STATES SPECIFIC CANCER IMMUNOTHERAPY DRUGS MANUFACTURERS PROFILES/ANALYSIS

6.1 Amgen
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Specific Cancer Immunotherapy Drugs Product Type, Application and Specification
    6.1.2.1 Tablet
    6.1.2.2 Injection
  6.1.3 Amgen Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.1.4 Main Business/Business Overview
6.2 Roche
  6.2.2 Specific Cancer Immunotherapy Drugs Product Type, Application and Specification
    6.2.2.1 Tablet
    6.2.2.2 Injection
  6.2.3 Roche Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.2.4 Main Business/Business Overview
6.3 Bristol Myers Squibb
  6.3.2 Specific Cancer Immunotherapy Drugs Product Type, Application and Specification
    6.3.2.1 Tablet
    6.3.2.2 Injection
  6.3.3 Bristol Myers Squibb Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.3.4 Main Business/Business Overview
6.4 Dendreon (Valeant)
  6.4.2 Specific Cancer Immunotherapy Drugs Product Type, Application and Specification
    6.4.2.1 Tablet
    6.4.2.2 Injection
  6.4.3 Dendreon (Valeant) Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.4.4 Main Business/Business Overview
6.5 Novartis
  6.5.2 Specific Cancer Immunotherapy Drugs Product Type, Application and Specification
    6.5.2.1 Tablet
    6.5.2.2 Injection
  6.5.3 Novartis Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.5.4 Main Business/Business Overview
6.6 Seattle Genetics
  6.6.2 Specific Cancer Immunotherapy Drugs Product Type, Application and Specification
    6.6.2.1 Tablet
    6.6.2.2 Injection
  6.6.3 Seattle Genetics Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.6.4 Main Business/Business Overview
6.7 Hangzhou Jinjiang Group
  6.7.2 Specific Cancer Immunotherapy Drugs Product Type, Application and Specification
    6.7.2.1 Tablet
    6.7.2.2 Injection
  6.7.3 Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
  6.7.4 Main Business/Business Overview

7 SPECIFIC CANCER IMMUNOTHERAPY DRUGS MANUFACTURING COST ANALYSIS

7.1 Specific Cancer Immunotherapy Drugs Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Specific Cancer Immunotherapy Drugs Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Specific Cancer Immunotherapy Drugs Major Manufacturers in 2015
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES SPECIFIC CANCER IMMUNOTHERAPY DRUGS MARKET FORECAST (2016-2021)

11.1 United States Specific Cancer Immunotherapy Drugs Sales, Revenue Forecast (2016-2021)
11.2 United States Specific Cancer Immunotherapy Drugs Sales Forecast by Type (2016-2021)
11.3 United States Specific Cancer Immunotherapy Drugs Sales Forecast by Application (2016-2021)
11.4 Specific Cancer Immunotherapy Drugs Price Forecast (2016-2021)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

Methodology
Analyst Introduction
Data Source

The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Picture of Specific Cancer Immunotherapy Drugs
Table Classification of Specific Cancer Immunotherapy Drugs
Figure United States Sales Market Share of Specific Cancer Immunotherapy Drugs by Type in 2015
Figure Tablet Picture
Figure Injection Picture
Table Application of Specific Cancer Immunotherapy Drugs
Figure United States Sales Market Share of Specific Cancer Immunotherapy Drugs by Application in 2015
Figure Leukemia Treatment Examples
Figure Colorectal Cancer Treatment Examples
Figure Other Cancer Treatment Examples
Figure United States Specific Cancer Immunotherapy Drugs Sales and Growth Rate (2011-2021)
Figure United States Specific Cancer Immunotherapy Drugs Revenue and Growth Rate (2011-2021)
Table United States Specific Cancer Immunotherapy Drugs Sales of Key Manufacturers (2015 and 2016)
Table United States Specific Cancer Immunotherapy Drugs Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Specific Cancer Immunotherapy Drugs Sales Share by Manufacturers
Figure 2016 Specific Cancer Immunotherapy Drugs Sales Share by Manufacturers
Table United States Specific Cancer Immunotherapy Drugs Revenue by Manufacturers (2015 and 2016)
Table United States Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers
Table 2016 United States Specific Cancer Immunotherapy Drugs Revenue Share by Manufacturers
Table United States Market Specific Cancer Immunotherapy Drugs Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Specific Cancer Immunotherapy Drugs Average Price of Key Manufacturers in 2015
Figure Specific Cancer Immunotherapy Drugs Market Share of Top 3 Manufacturers
Figure Specific Cancer Immunotherapy Drugs Market Share of Top 5 Manufacturers
Table United States Specific Cancer Immunotherapy Drugs Sales by States (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs Sales Share by States (2011-2016)
Figure United States Specific Cancer Immunotherapy Drugs Sales Market Share by States in 2015
Table United States Specific Cancer Immunotherapy Drugs Revenue and Market Share by States (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs Revenue Share by States (2011-2016)
Figure Revenue Market Share of Specific Cancer Immunotherapy Drugs by States (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs Price by States (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs Sales by Type (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs Sales Share by Type (2011-2016)
Figure United States Specific Cancer Immunotherapy Drugs Sales Market Share by Type in 2015
Table United States Specific Cancer Immunotherapy Drugs Revenue and Market Share by Type (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Specific Cancer Immunotherapy Drugs by Type (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs Price by Type (2011-2016)
Figure United States Specific Cancer Immunotherapy Drugs Sales Growth Rate by Type (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs Sales by Application (2011-2016)
Table United States Specific Cancer Immunotherapy Drugs Sales Market Share by Application (2011-2016)
Figure United States Specific Cancer Immunotherapy Drugs Sales Market Share by Application in 2015
Table United States Specific Cancer Immunotherapy Drugs Sales Growth Rate by Application (2011-2016)
Figure United States Specific Cancer Immunotherapy Drugs Sales Growth Rate by Application (2011-2016)
Table Amgen Basic Information List
Table Amgen Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Amgen Specific Cancer Immunotherapy Drugs Sales Market Share (2011-2016)
Table Roche Basic Information List
Table Roche Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Roche Specific Cancer Immunotherapy Drugs Sales Market Share (2011-2016)
Table Bristol Myers Squibb Basic Information List
Table Bristol Myers Squibb Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Bristol Myers Squibb Specific Cancer Immunotherapy Drugs Sales Market Share (2011-2016)
Table Dendreon (Valeant) Basic Information List
Table Dendreon (Valeant) Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Dendreon (Valeant) Specific Cancer Immunotherapy Drugs Sales Market Share (2011-2016)
Table Novartis Basic Information List
Table Novartis Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Novartis Specific Cancer Immunotherapy Drugs Sales Market Share (2011-2016)
Table Seattle Genetics Basic Information List
Table Seattle Genetics Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Seattle Genetics Specific Cancer Immunotherapy Drugs Sales Market Share (2011-2016)
Table Hangzhou Jinjiang Group Basic Information List
Table Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs Sales, Revenue, Price and Gross Margin (2011-2016)
Table Hangzhou Jinjiang Group Specific Cancer Immunotherapy Drugs Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Specific Cancer Immunotherapy Drugs
Figure Manufacturing Process Analysis of Specific Cancer Immunotherapy Drugs
Figure Specific Cancer Immunotherapy Drugs Industrial Chain Analysis
Table Raw Materials Sources of Specific Cancer Immunotherapy Drugs Major Manufacturers in 2015
Table Major Buyers of Specific Cancer Immunotherapy Drugs
Table Distributors/Traders List
Figure United States Specific Cancer Immunotherapy Drugs Production and Growth Rate Forecast (2016-2021)
Figure United States Specific Cancer Immunotherapy Drugs Revenue and Growth Rate Forecast (2016-2021)
Table United States Specific Cancer Immunotherapy Drugs Production Forecast by Type (2016-2021)
Table United States Specific Cancer Immunotherapy Drugs Consumption Forecast by Application (2016-2021)
Table United States Specific Cancer Immunotherapy Drugs Sales Forecast by States (2016-2021)
Table United States Specific Cancer Immunotherapy Drugs Sales Share Forecast by States (2016-2021)